Product Images Ciprofloxacin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Ciprofloxacin NDC 36000-298 by Baxter Healthcare Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Image 01-Description - Image 01 Description

Image 01-Description - Image 01 Description

Image 02-Logo - Image 02 Logo

Image 02-Logo - Image 02 Logo

Image 03-Container-01 - Image 03 Container 01

Image 03-Container-01 - Image 03 Container 01

Ciprofloxacin in Dextrose (5%) Injection is a prescription drug given through the veins, with each 100 mL of the solution containing 200 mg of Ciprofioxacin and 5 g Dextrose, adjusted to pH 3.5 to 4.6 using Hydrochloric acid. It should be infused over a period of 60 minutes and is meant for single use only. The drug additives should not be made to this solution. Dosage is to be directed by a physician and the accompanying Medication Guide should be dispensed to each patient. The caution is that it must not be used in series connection and should only be used if the solution is clear. It does not require any further dilution. The batch number of the product is AAAAAAAA and the expiration date is CCCCCCCC. It is manufactured by Baxter Pharmaceuticals India Private Ltd and is produced in a flexible plastic container.*

Image 04-Container-02.jpg - Image 04 Container 02

Image 04-Container-02.jpg - Image 04 Container 02

This is a prescription drug with the name AIN02857 NDC 36000-298-24 or Ciprofloxacin in Dextrose (5%) Injection, USP. It comes in a flexible plastic container of 200ml and should be infused over 60 minutes. Each 100 ml of this intravenous drug contains 200mg of Ciprofioxacin, 5g Dexirose Hydrous, Lactic Acid (added as solubilizer), Water for Injection, USP with pH adjusted with Hydrochloric acid. The drug is a sterile, nonpyrogenic solution that should not be tampered with. There are instructions for dosage that need to be followed, and accompanying medication guides should be dispensed to patients by pharmacists. Cautionary measures include not using this drug in series connections, maintaining the clarity of the solution, and not diluting it any further. M.L. No: GI28DILVP/14, Manufactured for Baxter Healthcare Corporation in Deerfield, IL 60015 USA, and Manufactured by Baxter Pharmaceuticals India Private Ltd, Ahmedabad 382213, India. The batch number is AAAAAAAA, and its expiration date is CCCCCCCC.*

Image 05-Logo - Image 05 Logo

Image 05-Logo - Image 05 Logo

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.